Cerevel Therapeutics Holdings, Inc. (NASDAQ:CERE – Get Rating) shares gapped down before the market opened on Wednesday . The stock had previously closed at $30.90, but opened at $28.85. Cerevel Therapeutics shares last traded at $29.70, with a volume of 306,874 shares traded. Analyst Ratings Changes Several research analysts have commented on the company. Wells […]
Shares of Cerevel Therapeutics Holdings, Inc. (NASDAQ:CERE – Get Rating) rose 7% during trading on Monday . The stock traded as high as $31.25 and last traded at $31.06. Approximately 383,386 shares changed hands during trading, a decline of 36% from the average daily volume of 594,443 shares. The stock had previously closed at $29.04. […]
HC Wainwright reissued their buy rating on shares of Cerevel Therapeutics (NASDAQ:CERE – Get Rating) in a research report sent to investors on Monday morning, Benzinga reports. They currently have a $45.00 price objective on the biotechnology company’s stock. CERE has been the subject of several other reports. Mizuho lowered their price objective on Cerevel […]
HC Wainwright reissued their buy rating on shares of Cerevel Therapeutics (NASDAQ:CERE – Get Rating) in a research note released on Monday, Benzinga reports. They currently have a $45.00 target price on the biotechnology company’s stock. A number of other research analysts have also recently commented on CERE. Wells Fargo & Company cut shares of […]
Cerevel Therapeutics Holdings, Inc. (NASDAQ:CERE – Get Rating) – Cantor Fitzgerald cut their FY2023 earnings per share estimates for Cerevel Therapeutics in a report issued on Thursday, February 23rd. Cantor Fitzgerald analyst C. Duncan now forecasts that the biotechnology company will post earnings of ($2.78) per share for the year, down from their prior forecast […]